#LABT Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences

#LABT Lakewood-Amedex Biotherapeutics Announces Participation in October Conferences
🚀 Zacks Small Cap Research - LABT: First Patient Dosed in Phase 2a Trial of Nu-3 for Infected Diabetic Foot Ulcers
🔎 Read the full update:
➡️https://theminingnews.com/zacks-small-cap-research-labt-first-patient-dosed-in-phase-2a-trial-of-nu-3-for-infected-diabetic-foot-ulcers/
#Nu3 #LABT #
#LABT Lakewood-Amedex Biotherapeutics Announces Positive Data Against Recent Clinical Isolates from Infected Diabetic Foot Ulcers
#LABT Lakewood-Amedex Biotherapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference